Wenbin X. Liu
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 10, 2026
Macrophage extracellular traps in autoimmunity: In vivo definition, pathogenic circuits, and therapeutic targeting.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 18, 2025
Single-cell analysis reveals shared adaptive responses across different types of podocyte injury.
Journal: Frontiers in immunology
Published: October 03, 2025
Multi-omics analysis suggests a potential role of the complement-coagulation axis in hypercoagulability of membranous nephropathy.
Journal: International urology and nephrology
Published: October 01, 2025
Heterogeneity of Renal Endothelial Cells, Interact with Neighboring Cells, and Endothelial Injury in Chronic Kidney Disease: Mechanisms and Therapeutic Implications.
Journal: International journal of medical sciences
Published: December 06, 2024
B cell dysregulation and depletion therapy in primary membranous nephropathy: Prospects and potential challenges.
Journal: International immunopharmacology
Published: April 29, 2024
Efficacy and safety of Mahuang Fuzi and Shenzhuo Decoction for treatment of primary membranous nephropathy: a multicenter prospective trial.
Journal: Renal failure
Published: March 14, 2024
A simple protocol to establish a conditionally immortalized mouse podocyte cell line.
Journal: Scientific reports
Published: January 23, 2024
Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction (MFSD) to repair podocyte damage.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: December 30, 2023
Experimental models for elderly patients with membranous nephropathy: Application and advancements.
Journal: Experimental gerontology
Published: October 14, 2023
Corrigendum: MicroRNAs: Potential mediators between particulate matter 2.5 and Th17/Treg immune disorder in primary membranous nephropathy.
Journal: Frontiers in pharmacology
Published: February 15, 2023
Cytokines network in primary membranous nephropathy.
Journal: International immunopharmacology
Published: August 17, 2022
Last Updated: 09/26/2026